IT1271624B - Derivati glucosidici di n-acil alchilamine capaci di esercitare effetto o neuroprotettivo utilizzabili nelle patologie acute e croniche del sistema nervoso centrale correlate ad eccitotossicita' - Google Patents
Derivati glucosidici di n-acil alchilamine capaci di esercitare effetto o neuroprotettivo utilizzabili nelle patologie acute e croniche del sistema nervoso centrale correlate ad eccitotossicita'Info
- Publication number
- IT1271624B IT1271624B ITMI940524A ITMI940524A IT1271624B IT 1271624 B IT1271624 B IT 1271624B IT MI940524 A ITMI940524 A IT MI940524A IT MI940524 A ITMI940524 A IT MI940524A IT 1271624 B IT1271624 B IT 1271624B
- Authority
- IT
- Italy
- Prior art keywords
- acyl
- acute
- nervous system
- central nervous
- alchylamines
- Prior art date
Links
- 230000001154 acute effect Effects 0.000 title abstract 2
- 210000003169 central nervous system Anatomy 0.000 title abstract 2
- 230000001684 chronic effect Effects 0.000 title abstract 2
- 230000000694 effects Effects 0.000 title 1
- 230000003492 excitotoxic effect Effects 0.000 title 1
- 231100000063 excitotoxicity Toxicity 0.000 title 1
- 230000000324 neuroprotective effect Effects 0.000 title 1
- 102000018899 Glutamate Receptors Human genes 0.000 abstract 1
- 108010027915 Glutamate Receptors Proteins 0.000 abstract 1
- 229930182478 glucoside Natural products 0.000 abstract 1
- 150000008131 glucosides Chemical class 0.000 abstract 1
- 230000007170 pathology Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Genetics & Genomics (AREA)
- Cardiology (AREA)
- Ophthalmology & Optometry (AREA)
- Crystallography & Structural Chemistry (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Abstract
Si descrivono nuovi derivati glucosidici di N-acil alchilamine e il loro impiego nella cura di patologie acute e croniche del sistema nervoso centrale correlate a sovrastimolazione dei recettori agli amminoacidi eccitatori.
Priority Applications (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITMI940524A IT1271624B (it) | 1994-03-21 | 1994-03-21 | Derivati glucosidici di n-acil alchilamine capaci di esercitare effetto o neuroprotettivo utilizzabili nelle patologie acute e croniche del sistema nervoso centrale correlate ad eccitotossicita' |
AT95928857T ATE169629T1 (de) | 1994-03-21 | 1995-03-20 | Glukosid-derivate von n-acyl-alkylaminen mit neuroprotektiver,neurotrophischer und entzündungshemmender wirkung für die behandlung von zentralnervensystemerkrankungen |
ES95928857T ES2124012T3 (es) | 1994-03-21 | 1995-03-20 | Derivados glucosidicos de n-acilalquilaminas que ejercen accion neuroprotectora y neurotrofica utiles en trastornos agudos y cronicos del sistema nervioso central relacionados con excitotoxicidad. |
EP95928857A EP0751947B1 (en) | 1994-03-21 | 1995-03-20 | Glucosidic derivatives of n-acyl alkylamines exerting neuroprotective, neurotrophic and anti-inflammatory action, useful in acute and chronic disorders of the central nervous system connected with excitotoxicity |
DK95928857T DK0751947T3 (da) | 1994-03-21 | 1995-03-20 | Glucosidderivater af N-acylalkylaminer, der udøver neurobeskyttende, neurotrop og anti-inflammatorisk virkning, og som er a |
AU21100/95A AU2110095A (en) | 1994-03-21 | 1995-03-20 | Glucosidic derivatives of n-acyl alkylamines exerting neuroprotective, neurotrophic and anti-inflammatory action, useful in acute and chronic disorders of the central nervous system connected with excitotoxicity |
JP52438195A JP4063864B2 (ja) | 1994-03-21 | 1995-03-20 | 興奮性毒性に関連した中枢神経系の急性ならびに慢性障害に有用な、神経保護、神経栄養、ならびに抗炎症作用を有するn−アシルアルキルアミンのグルコシド誘導体 |
CA002186245A CA2186245C (en) | 1994-03-21 | 1995-03-20 | Glucosidic derivatives of n-acyl alkylamines exerting neuroprotective, neurotrophic and anti-inflammatory action, useful in acute and chronic disorders of the central nervous system connected with excitotoxicity |
DE69504048T DE69504048T2 (de) | 1994-03-21 | 1995-03-20 | Glukosid-derivate von n-acyl-alkylaminen mit neuroprotektiver,neurotrophischer und entzündungshemmender wirkung für die behandlung von zentralnervensystemerkrankungen |
PCT/EP1995/001026 WO1995025736A1 (en) | 1994-03-21 | 1995-03-20 | Glucosidic derivatives of n-acyl alkylamines exerting neuroprotective, neurotrophic and anti-inflammatory action, useful in acute and chronic disorders of the central nervous system connected with excitotoxicity |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITMI940524A IT1271624B (it) | 1994-03-21 | 1994-03-21 | Derivati glucosidici di n-acil alchilamine capaci di esercitare effetto o neuroprotettivo utilizzabili nelle patologie acute e croniche del sistema nervoso centrale correlate ad eccitotossicita' |
Publications (3)
Publication Number | Publication Date |
---|---|
ITMI940524A0 ITMI940524A0 (it) | 1994-03-21 |
ITMI940524A1 ITMI940524A1 (it) | 1995-09-21 |
IT1271624B true IT1271624B (it) | 1997-06-04 |
Family
ID=11368282
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ITMI940524A IT1271624B (it) | 1994-03-21 | 1994-03-21 | Derivati glucosidici di n-acil alchilamine capaci di esercitare effetto o neuroprotettivo utilizzabili nelle patologie acute e croniche del sistema nervoso centrale correlate ad eccitotossicita' |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP0751947B1 (it) |
JP (1) | JP4063864B2 (it) |
AT (1) | ATE169629T1 (it) |
AU (1) | AU2110095A (it) |
DE (1) | DE69504048T2 (it) |
DK (1) | DK0751947T3 (it) |
ES (1) | ES2124012T3 (it) |
IT (1) | IT1271624B (it) |
WO (1) | WO1995025736A1 (it) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4070966B2 (ja) * | 2001-06-28 | 2008-04-02 | 株式会社カネボウ化粧品 | 新規ガラクトシルセラミド類縁体及び用途 |
EP1844784B1 (en) * | 2006-03-28 | 2010-04-21 | Epitech Group S.r.l. | A pharmaceutical composition for the treatment of pathologies caused by the general response of the immune system |
KR101116868B1 (ko) * | 2008-10-20 | 2012-02-29 | 성균관대학교산학협력단 | 안질환의 예방 또는 치료용 조성물 |
US9828341B2 (en) | 2012-11-28 | 2017-11-28 | Victoria Link Limited | Dendritic core compounds |
CN105102466B (zh) * | 2012-11-28 | 2018-07-27 | 维多利亚林克有限公司 | 作为bace-1的抑制剂的糖树枝状簇化合物 |
CN105418698B (zh) * | 2015-12-21 | 2018-04-27 | 上海市第七人民医院 | 一种酰胺乙氧基-β-D-葡萄糖苷类化合物及其制备方法和应用 |
US11186603B2 (en) | 2017-03-23 | 2021-11-30 | Victoria Link Limited | Heparan sulfate glycomimetic compounds and their pharmaceutical and cosmeceutical uses |
CN115466178B (zh) * | 2021-06-11 | 2024-06-11 | 青岛海合生物科技有限公司 | 一种神经酸衍生物及其制备方法和应用 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1260156B (it) * | 1992-08-03 | 1996-03-28 | Fidia Spa | Derivati dell'acido neuraminico |
-
1994
- 1994-03-21 IT ITMI940524A patent/IT1271624B/it active IP Right Grant
-
1995
- 1995-03-20 AT AT95928857T patent/ATE169629T1/de not_active IP Right Cessation
- 1995-03-20 EP EP95928857A patent/EP0751947B1/en not_active Expired - Lifetime
- 1995-03-20 JP JP52438195A patent/JP4063864B2/ja not_active Expired - Lifetime
- 1995-03-20 DE DE69504048T patent/DE69504048T2/de not_active Expired - Lifetime
- 1995-03-20 AU AU21100/95A patent/AU2110095A/en not_active Abandoned
- 1995-03-20 DK DK95928857T patent/DK0751947T3/da active
- 1995-03-20 WO PCT/EP1995/001026 patent/WO1995025736A1/en active IP Right Grant
- 1995-03-20 ES ES95928857T patent/ES2124012T3/es not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
DK0751947T3 (da) | 1999-05-10 |
DE69504048T2 (de) | 1999-04-22 |
JPH09510469A (ja) | 1997-10-21 |
JP4063864B2 (ja) | 2008-03-19 |
AU2110095A (en) | 1995-10-09 |
ITMI940524A1 (it) | 1995-09-21 |
ATE169629T1 (de) | 1998-08-15 |
EP0751947A1 (en) | 1997-01-08 |
WO1995025736A1 (en) | 1995-09-28 |
ITMI940524A0 (it) | 1994-03-21 |
ES2124012T3 (es) | 1999-01-16 |
DE69504048D1 (de) | 1998-09-17 |
EP0751947B1 (en) | 1998-08-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ID28003A (id) | Turunan-turunan adamantana | |
BR0015611A (pt) | Processo de limpeza que utiliza ondas ultra-sÈnicas | |
BR9712808A (pt) | Indol-3-glioxilamidas n-substituìdas com efeito antiasmático, anti-alérgico e imunossupressor/imunomodulador | |
HUP9800033A3 (en) | Compositions for the treatment of dermatological disorders and methods for their use | |
IL122733A0 (en) | Pharmaceutical compositions for use in the treatment of allergic asthma | |
HUP9601161A2 (en) | Use of retinoids in cosmetic compositions or for the manufacture of pharmaceutical compositions | |
EE9600018A (et) | 2,9-diasendatud puriin-6-oonid, nende valmistamismeetod, kasutamine ravimite valmistamiseks ja nimetatud ühendeid sisaldavad ravimid | |
MY115211A (en) | Novel amino acid derivatives, their preparation and use | |
IT1271624B (it) | Derivati glucosidici di n-acil alchilamine capaci di esercitare effetto o neuroprotettivo utilizzabili nelle patologie acute e croniche del sistema nervoso centrale correlate ad eccitotossicita' | |
PT942741E (pt) | Composicoes de lectina e suas utilizacoes | |
ITMI992107A0 (it) | Uso del baclofen nel trattamento dell'astinenza da etanolo | |
RS49599B (sr) | Upotreba inhibitora h+, k+-atp-aze i glukokortikoida i farmaceutska formulacija | |
IL115589A0 (en) | Use of cck-b antagonists in pharmaceutical compositions | |
NO970178D0 (no) | Terpenoidderivater (sarcodictyiner) som er nyttige som antitumormidler | |
AU5963396A (en) | Cis-resorcylide, pharmaceutical composition containing it, use thereof in the treatment of thrombosis and related disorders | |
IT8519907A0 (it) | Prodotto farmaceutico cosmetico, in particolare per la cura di acne e seborrea. | |
ES2105672T3 (es) | (s)-malato de (s)-alfa-fenil-2-piridinetanamina y su utilizacion como medicamento. | |
ATE175971T1 (de) | Wasserlösliche retinoide | |
NZ268039A (en) | Use of efaroxan in treating parkinson's disease | |
ZA969832B (en) | New quinoxalinedione derivatives their production and use in pharmaceutical agents | |
CA2186245A1 (en) | Glucosidic derivatives of n-acyl alkylamines exerting neuroprotective, neurotrophic and anti-inflammatory action, useful in acute and chronic disorders of the central nervous system connected with excitotoxicity | |
ZA9610264B (en) | Preparation for use in the treatment of skin disorders. | |
BG102009A (en) | Method for the treatment of manic and two-pole disease | |
NO974687D0 (no) | Kondenserte <beta>-carboliner | |
ITUD950019V0 (it) | Condensatore antiscoppio perfezionato nella struttura del sistema antiscoppio |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
0001 | Granted | ||
TA | Fee payment date (situation as of event date), data collected since 19931001 |
Effective date: 19970227 |